Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for JMDCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 511.08M
March 31, 2026 525.97M
December 31, 2025 522.58M
September 30, 2025 538.17M
June 30, 2025 540.32M
March 31, 2025 521.75M
December 31, 2024 472.07M
September 30, 2024 503.88M
June 30, 2024 437.00M
March 31, 2024 466.42M
December 31, 2023 496.20M
September 30, 2023 459.94M
June 30, 2023 455.64M
March 31, 2023 484.71M
December 31, 2022 476.54M
Date Value
September 30, 2022 425.84M
June 30, 2022 231.24M
March 31, 2022 256.81M
December 31, 2021 261.86M
September 30, 2021 259.39M
June 30, 2021 254.82M
March 31, 2021 255.66M
December 31, 2020 257.20M
September 30, 2020 97.33M
June 30, 2020 90.61M
March 31, 2020 121.56M
December 31, 2019 115.58M
September 30, 2019 62.51M
June 30, 2019
March 31, 2019 55.26M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. 7.053M
SCWorx Corp. 6.932M
Health Catalyst, Inc. 100.83M
M3, Inc. 2.499B
GoodRx Holdings, Inc. 647.60M

Shareholders Equity (Quarterly) Related Metrics